🕵️ Avanos Medical, Inc. ($AVNS)
SEC insider & ownership activity, last 12 months · CIK 1606498 · every row links its SEC filing
Over the last 12 months insiders sold $165K against $659K of open-market buying. Blackford Gary bought $659K in discretionary trades (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $659K (2 lots) · 1 seller, $165K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Blackford Gary | 2 | $659K | 0 | – | Aug 13, 2025 |
| Holbrook Kerr | 0 | – | 4 | $165K | Nov 18, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.8% | 13G | Apr 30, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Holbrook Kerr | $165K | Nov 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jul 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 22, 2026 | filing ↗ |
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 25, 2026 | filing ↗ |
| Other events (8.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 21, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 21, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 15, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |